COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Neuraly develops disease‑modifying therapeutics for Parkinson’s and Alzheimer’s, advancing a brain‑penetrant, long‑acting GLP‑1R agonist (NLY01) from Johns Hopkins research alongside two early‑stage pipeline candidates.
